European Atherosclerosis Society (EAS) & Congress

European Atherosclerosis Society (EAS) & Congress For more than 50 years the Society’s expertise has been used to teach clinicians how to manage lipid disorders and how to prevent atherosclerosis.

The European Atherosclerosis Society (EAS) was founded in 1964 with the aim of “advancing and exchanging knowledge concerning the causes, natural history, treatment and prevention of atherosclerotic disease”. By offering to our members access to educational materials, and opportunities to take part in Congress and courses, and by providing a forum in which new developments can be discussed, EAS co

ntributes to the development of knowledge in the field, and ultimately to the improved treatment of persons with cardiovascular disease and lipid disorders. In recent years the Society has made a particular effort to recruit young scientists and clinicians also from other related disciplines. What we do
The European Atherosclerosis Society’s goal is to provide a framework for concerted scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis. EAS is active in the publication of Guidelines and Consensus Position Papers, and its official Journal is Atherosclerosis. Through a regular series of Featured Commentaries EAS puts into perspective topical issues of relevance to our members. The Society organizes an annual Congress for approximately 2000 delegates, and runs a programme of Advanced Courses for both basic scientists and clinicians. EAS Academy is the Society's online e-Learning resource, containing a range of educational material and self-teaching programmes.

Research and education are essential components of lipid clinics. Research helps improve the understanding, diagnosis, a...
26/06/2026

Research and education are essential components of lipid clinics. Research helps improve the understanding, diagnosis, and treatment of lipid disorders, while participation in clinical trials and patient registries supports the development of new therapies. Integrating research into clinical practice contributes to better prevention and management of ASCVD and other lipid-related conditions.

Continuous education for clinic staff, healthcare professionals, and patients is equally important to ensure optimal care. Ongoing learning through educational networks, scientific literature, and training activities helps professionals stay updated on advances in lipidology. Patient education, ideally involving patient organizations and caregivers, also plays a key role in improving disease understanding and treatment adherence.

The Consensus Statement recommends several approaches to support these goals: https://eas.to/lcn-consensus-2026-harmonization-education

The transition from paediatric to adult healthcare involves changes in care teams and system design.As a result, adolesc...
25/06/2026

The transition from paediatric to adult healthcare involves changes in care teams and system design.

As a result, adolescents and young adults are often overlooked, leading to a lack of follow-up and loss of compliance. Young people often consider healthcare of low importance compared with other aspects of their transition to adulthood, such as education, employment and relationships. Therefore, it is essential to begin educating them about FH and its management as early as possible, and by 10 years at the latest. Better education of young people with FH should improve long-term adherence to clinical management.

Although cardiac events are rare in children with FH, they can occur in those with HoFH and in young adults with severe HeFH. It is vital that young people recognise symptoms and know to seek urgent medical help, particularly as they transition to adult care and independent living.

Key proposals for transition from childhood to adulthood are summarized here: https://eas.to/consensus-fhinchildren-2026-toadultcare

The LCN Bosnia & Herzegovina webinar will translate the Consensus Statement on Systemic Metabolic Disorders into practic...
22/06/2026

The LCN Bosnia & Herzegovina webinar will translate the Consensus Statement on Systemic Metabolic Disorders into practical guidance for everyday patient care. Join us to learn how these recommendations are being applied on the local level, how they can help optimize clinical management, and what challenges remain. Register here: https://eas.to/LCNWebConBIH

Before the end of the month, don't miss our fantastic Featured Open Lecture: May–June. In this engaging presentation, Dr...
21/06/2026

Before the end of the month, don't miss our fantastic Featured Open Lecture: May–June. In this engaging presentation, Dr Jaimini Cegla explores the topical and controversial issue of cascade screening in families of index cases with elevated Lp(a) concentrations. Drawing on her extensive clinical, laboratory, and academic experience, she presents a balanced review of the arguments both for and against this approach: https://eas.to/OpenMay26

Haven't you registered for the EAS Paediatric Lipidology Summer School – Lifelong Prevention Begins in Childhood yet? Re...
19/06/2026

Haven't you registered for the EAS Paediatric Lipidology Summer School – Lifelong Prevention Begins in Childhood yet? Remember, applications are open only until 9 July, so don't miss your chance to apply.
📖 Learn more about the programme, application process, and participation requirements, make your decision, and join us in Ljubljana: https://eas.to/SummerSchool

Effective communication and dissemination of information to patients with inherited hyperlipidaemias and other lipid dis...
19/06/2026

Effective communication and dissemination of information to patients with inherited hyperlipidaemias and other lipid disorders are important, as early and lifelong management is needed to prevent adverse outcomes. Providing accurate, tailored information helps patients understand their condition and improves adherence to lifestyle changes and treatment. In a simple way, learn more about the following points from our dedicated webpage: https://eas.to/lcn-consensus-2026-harmonization-patientmanagement

🔵 How can patient education be improved?
🔵 Which patients should be followed in lipid clinics?
🔵 Frequency of follow-up
🔵 The patient perspective
🔵 Adherence to dietary advice
🔵 Adherence to other lifestyle advice
🔵 Adherence or persistence to medication
🔵 Understanding genetic test results

🇷🇴 LCN Webinar on Systemic Metabolic Disorders comes to Romania! On 23 June, join local experts & discover: ✔ current tr...
18/06/2026

🇷🇴 LCN Webinar on Systemic Metabolic Disorders comes to Romania! On 23 June, join local experts & discover:

✔ current trends in obesity and related metabolic disorders
✔ the links between excess adiposity, dyslipidaemia, and insulin resistance
✔ long-term cardiovascular consequences of systemic metabolic disorders
✔ practical implementation of the Consensus Statement in Romania

Register here: https://eas.to/LCNWebConRom

Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her ...
17/06/2026

Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating field. Discover how cells store and mobilize fat, why maintaining the balance between these processes is essential for metabolic health, and which lipid hydrolases still remain to be discovered.

Beyond the science, Dagmar Kratky also shares personal insights into the key milestones of her career and offers inspiring advice for young scientists: “Stay persistent, try again, never give up, and never take it personally — just try again, and it will work.”

Listen to an inspiring conversation about scientific curiosity, resilience, and the future of lipid research:

🎧 Spotify: https://eas.to/ATHTalkE35S
🎧 Apple Podcasts: https://eas.to/ATHTalkE35A
🎧 Youtube: https://eas.to/ATHTalkE35Y

Things move fast, and we'll soon be together for the first webinar on Familial Hypercholesterolaemia (FH) in children an...
16/06/2026

Things move fast, and we'll soon be together for the first webinar on Familial Hypercholesterolaemia (FH) in children and adolescents.

This is an event you won't want to miss. Make sure you're registered and, most importantly, join us tomorrow afternoon for a knowledge-rich session. There is no better way to learn than by interacting directly with experts: https://eas.to/WebFHinChildren1Reg

Adress

Första Långgatan 4A
Gothenburg
41303

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när European Atherosclerosis Society (EAS) & Congress postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Affären

Skicka ett meddelande till European Atherosclerosis Society (EAS) & Congress:

Genvägar

Dela